Series 39 Antifraud Rules, Confirmations, Control Disclosure, and Unregistered Activity (2.1) Guide

This Series 39 lesson covers antifraud rules, confirmations, control disclosure, and unregistered activity (2.1) within Sales Supervision, General Supervision of Employees, Regulatory Framework of FINRA. Read it as a DPP principal supervision lesson: the exam usually asks what must be reviewed, approved, restricted, disclosed, documented, or escalated so the offering process and customer recommendation stay compliant.

Learning Objectives

• Apply Rules 10b-1, 10b-3, and 10b-5 to false, misleading, or omitted material information in DPP sales or supervision.
• Determine what confirmation disclosure is required under Rule 10b-10 for a DPP transaction.
• Assess when a person or firm is acting as an unregistered broker-dealer in violation of Section 15(a)(1).
• Explain how sanctions against broker-dealers or associated persons under Section 15 shape principal escalation decisions.
• Distinguish general antifraud exposure from specific misrepresentation of registration or control status.
• Evaluate when Rule 15c1-5 requires disclosure of a control relationship with the issuer in a DPP sale.
• Select the best response when a DPP sales practice creates both antifraud and registration-status concerns.

Key Concepts

• Series 39 supervision follows the DPP sale from representative conduct through customer documentation and post-sale evidence.
• Registration status, communications, suitability, retirement-plan issues, outside activities, and information controls can be the actual issue even when the product is a DPP.
• The best principal answer protects the customer and the firm before the conduct becomes a complaint or regulatory problem.

Exam Focus

This section is most likely to test broker-dealer status, antifraud obligations, confirmations, privacy, insider trading, installment-sales treatment, adviser-registration triggers, FINRA registration and conduct rules, outside activities, investigations, arbitration, retirement plans, ERISA, rollovers, UBTI, and prohibited transactions. Strong answers identify the DPP-specific control issue before choosing a generic principal response. Weak answers often use broad supervision language while missing the offering structure, compensation arrangement, investor-entry control, customer disclosure, or financial-responsibility evidence that actually controls the stem.

Series 39 questions often combine two layers: the DPP feature and the principal action. Do not stop after recognizing the product. Ask what the principal should have reviewed before approval, what evidence should exist in the file, and what restriction or escalation follows if the facts are incomplete.

How to Apply This Section

Identify what the associated person, supervisor, customer, or firm did before reanalyzing the DPP product. If the facts show misleading communication, inadequate suitability, outside activity, privacy weakness, possible MNPI, retirement-plan complexity, or unclear registration status, the best answer usually tightens review, restricts activity, escalates, and documents.

Use this sequence when a question includes many facts:

Decision Table

Common Pitfalls

• Solving the product structure while ignoring the conduct failure.
• Underestimating retirement-plan, rollover, UBTI, or prohibited-transaction risk.
• Waiting for proof of misuse before restricting or escalating information-control problems.

Review Checklist

Before leaving this section, make sure you can address these points:

• Apply Rules 10b-1, 10b-3, and 10b-5 to false, misleading, or omitted material information in DPP sales or supervision.
• Determine what confirmation disclosure is required under Rule 10b-10 for a DPP transaction.
• Assess when a person or firm is acting as an unregistered broker-dealer in violation of Section 15(a)(1).
• Explain how sanctions against broker-dealers or associated persons under Section 15 shape principal escalation decisions.
• Distinguish general antifraud exposure from specific misrepresentation of registration or control status.
• Evaluate when Rule 15c1-5 requires disclosure of a control relationship with the issuer in a DPP sale.
• Select the best response when a DPP sales practice creates both antifraud and registration-status concerns.
• Explain what makes the issue DPP-specific rather than generic principal supervision.
• State what evidence a Series 39 principal should expect to review or preserve.

Key Takeaways

• Series 39 rewards DPP-specific principal judgment, not generic supervision language alone.
• The best answer usually identifies the offering or conduct control, then chooses a documented supervisory response.
• Due diligence, compensation, communications, suitability, and financial responsibility often overlap in one fact pattern.
• When facts are incomplete or investor-facing risk is high, approval should wait until the principal can support the decision.